Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 2001 Mar;56(3):218–222. doi: 10.1136/thorax.56.3.218

Assessment of quality of life in lung transplantation using a simple generic tool

A Anyanwu 1, A McGuire 1, C Rogers 1, A Murday 1
PMCID: PMC1758767  PMID: 11182015

Abstract

BACKGROUND—The EuroQol is a generic questionnaire developed to provide a simple method for assigning utility values to health. This study examines the applicability of the EuroQol to the measurement of quality of life in single, bilateral, and heart-lung transplantation.
METHODS—A cross sectional study was performed in 87 patients awaiting lung transplantation and in 255 transplant recipients attending follow up clinics in four transplant units.
RESULTS—In the waiting list group 61% reported extreme problems in at least one of the five EuroQol quality of life domains compared with 20% single lung recipients, 4% bilateral lung recipients, and 2% heart-lung recipients at 3 or more years after transplantation. The mean utility value of patients on the waiting list was 0.31.In comparison, utility values for recipients 3 years after transplantation were 0.61 for single, 0.82 for bilateral, and 0.87 for heart-lung transplants. The utility scores and health profiles of bilateral and heart-lung recipients were consistently superior to those of single lung recipients. Problems in all five domains were more frequent in single lung recipients. Subjective assessment with a visual analogue scale showed a similar trend.
CONCLUSIONS—The EuroQol is a simple method of deriving a single utility value for quality of life and is responsive to changes after lung transplantation. It is worth considering as a means of monitoring quality of life after transplantation and as an index of quality of survival in research studies in solid organ transplantation. These data suggest that quality of life after transplantation of one lung is inferior to that after transplantation of two lungs.



Full Text

The Full Text of this article is available as a PDF (104.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Al M. J., Koopmanschap M. A., van Enckevort P. J., Geertsma A., van der Bij W., de Boer W. J., TenVergert E. M. Cost-effectiveness of lung transplantation in The Netherlands: a scenario analysis. Chest. 1998 Jan;113(1):124–130. doi: 10.1378/chest.113.1.124. [DOI] [PubMed] [Google Scholar]
  2. Anyanwu A. C., Rogers C. A., Murday A. J. Variations in cardiac transplantation: comparisons between the United Kingdom and the United States. J Heart Lung Transplant. 1999 Apr;18(4):297–303. doi: 10.1016/s1053-2498(98)00051-5. [DOI] [PubMed] [Google Scholar]
  3. Bavaria J. E., Kotloff R., Palevsky H., Rosengard B., Roberts J. R., Wahl P. M., Blumenthal N., Archer C., Kaiser L. R. Bilateral versus single lung transplantation for chronic obstructive pulmonary disease. J Thorac Cardiovasc Surg. 1997 Mar;113(3):520–528. doi: 10.1016/S0022-5223(97)70365-9. [DOI] [PubMed] [Google Scholar]
  4. Brooks R. EuroQol: the current state of play. Health Policy. 1996 Jul;37(1):53–72. doi: 10.1016/0168-8510(96)00822-6. [DOI] [PubMed] [Google Scholar]
  5. Busschbach J. J., Horikx P. E., van den Bosch J. M., Brutel de la Rivière A., de Charro F. T. Measuring the quality of life before and after bilateral lung transplantation in patients with cystic fibrosis. Chest. 1994 Mar;105(3):911–917. doi: 10.1378/chest.105.3.911. [DOI] [PubMed] [Google Scholar]
  6. Caine N., Sharples L. D., Smyth R., Scott J., Hathaway T., Higenbottam T. W., Wallwork J. Survival and quality of life of cystic fibrosis patients before and after heart-lung transplantation. Transplant Proc. 1991 Feb;23(1 Pt 2):1203–1204. [PubMed] [Google Scholar]
  7. Dennis C., Caine N., Sharples L., Smyth R., Higenbottam T., Stewart S., Wreghitt T., Large S., Wells F. C., Wallwork J. Heart-lung transplantation for end-stage respiratory disease in patients with cystic fibrosis at Papworth Hospital. J Heart Lung Transplant. 1993 Nov-Dec;12(6 Pt 1):893–902. [PubMed] [Google Scholar]
  8. Dolan P. Modeling valuations for EuroQol health states. Med Care. 1997 Nov;35(11):1095–1108. doi: 10.1097/00005650-199711000-00002. [DOI] [PubMed] [Google Scholar]
  9. Gartner S. H., Sevick M. A., Keenan R. J., Chen G. J. Cost-utility of lung transplantation: a pilot study. J Heart Lung Transplant. 1997 Nov;16(11):1129–1134. [PubMed] [Google Scholar]
  10. Geertsma A., Ten Vergert E. M., Bonsel G. J., de Boer W. J., van der Bij W. Does lung transplantation prolong life? A comparison of survival with and without transplantation. J Heart Lung Transplant. 1998 May;17(5):511–516. [PubMed] [Google Scholar]
  11. Gross C. R., Raghu G. The cost of lung transplantation and the quality of life post-transplant. Clin Chest Med. 1997 Jun;18(2):391–403. doi: 10.1016/s0272-5231(05)70387-7. [DOI] [PubMed] [Google Scholar]
  12. Hosenpud J. D., Bennett L. E., Keck B. M., Edwards E. B., Novick R. J. Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease. Lancet. 1998 Jan 3;351(9095):24–27. doi: 10.1016/S0140-6736(97)06405-2. [DOI] [PubMed] [Google Scholar]
  13. Michel B. C., Van Hout B. A., Bonsel G. J. Assessing the benefits of transplant services. Baillieres Clin Gastroenterol. 1994 Sep;8(3):411–423. doi: 10.1016/0950-3528(94)90028-0. [DOI] [PubMed] [Google Scholar]
  14. TenVergert E. M., Essink-Bot M. L., Geertsma A., van Enckevort P. J., de Boer W. J., van der Bij W. The effect of lung transplantation on health-related quality of life: a longitudinal study. Chest. 1998 Feb;113(2):358–364. doi: 10.1378/chest.113.2.358. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES